Investors Watch List: Amgen Inc. (NASDAQ:AMGN), Carolina Trust Bank (NASDAQ:CART), Medallion Financial Corp. (NASDAQ:TAXI), Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC),

Amgen (NASDAQ:AMGN) announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for BLINCYTO® (blinatumomab) to include new data supporting the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BLINCYTO, the first-and-only FDA-approved bispecific CD19-directed CD3 T cell engager (BiTE®) immunotherapy, is currently available under an accelerated approval in the U.S. for the treatment of Ph- relapsed or refractory B-cell precursor ALL, a rare and rapidly progressing cancer of the blood and bone marrow impacting both adults and children.

Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 32.00% and weekly performance is 0.77%. On last trading day company shares ended up at $148.39.

Carolina Trust Bank (NASDAQ:CART) shares increased 0.34% in last trading session and ended the day at $5.95. CART return on assets is 2.20%. Carolina Trust Bank (NASDAQ:CART) quarterly performance is -2.30%.

On 17 February, Medallion Financial Corp. (NASDAQ:TAXI) announced that earnings, or net increase in net assets resulting from operations, were $29,376,000 or $1.20 per diluted common share in 2015, up $684,000 or 2% from $28,692,000 or $1.14 per share in 2014, primarily reflecting lower operating expenses and higher net interest income, partially offset by lower net realized/unrealized gains and noninterest income. Net investment income after income taxes was $16,826,000 or $0.69 per share in 2015, up $1,681,000 or 11% from $15,145,000 or $0.60 in 2014.

On 01 March, Medallion Financial Corp. (NASDAQ:TAXI) shares increased 1.24% and was closed at $8.18. TAXI EPS growth in last 5 year was 13.40%. Medallion Financial Corp. (NASDAQ:TAXI) year to date (YTD) performance is 16.19%.

Anacor Pharma (NASDAQ: ANAC) reported Q4 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $21.2 million versus the consensus estimate of $27.93 million.

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) ended the last trading day at $62.31. Company weekly volatility is calculated as 10.58% and price to cash ratio as 18.43. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) showed a weekly performance of -6.96%.

Ford Motor Companys (NYSE: F) U.S. sales were up 20.2 percent in February versus a year ago with 217,192 vehicles sold. Retail sales grew 11 percent the companys best February since 2005. (The Street consensus called for a 12.6 percent gain for the month.)

Ford Motor Company (NYSE:F) shares moved up 4.64% in last trading session and ended the day at $13.09. F Gross Margin is 15.40% and its return on assets is 3.40%. Ford Motor Company (NYSE:F) quarterly performance is -6.87%.

Leave a Reply

Your email address will not be published. Required fields are marked *